SBIR/STTR Research Award
Recombinant Immuno-Fragments for C. difficile detection
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MERIDIAN BIOSCIENCE, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- HWJ5BXUMNGK5
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): The overall goal of this proposed Phase I project is to determine scientific merit and feasibility of constructing highly specific recombinant single chain variable fragment (scFv) antibodies to Clostridium difficile
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- ANTIGENS RELEVANT TO THE DIAGNOSIS OF MYCOPLASMA HOMINIS
- ANTIGENS RELEVANT TO THE DIAGNOSIS OF MYCOPLASMA HOMINIS
Research funding history
3 SBIR/STTR records share this UEI (1988–2004). Reported award amounts total $606,251. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services